IRON Financial LLC Sells 480 Shares of CVS Health Co. (NYSE:CVS)

IRON Financial LLC cut its holdings in shares of CVS Health Co. (NYSE:CVSFree Report) by 4.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,434 shares of the pharmacy operator’s stock after selling 480 shares during the period. IRON Financial LLC’s holdings in CVS Health were worth $745,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Vanguard Group Inc. boosted its stake in CVS Health by 0.4% in the third quarter. Vanguard Group Inc. now owns 117,162,626 shares of the pharmacy operator’s stock valued at $8,180,295,000 after acquiring an additional 485,744 shares in the last quarter. State Street Corp raised its holdings in shares of CVS Health by 1.6% in the second quarter. State Street Corp now owns 55,877,387 shares of the pharmacy operator’s stock worth $3,862,804,000 after buying an additional 855,269 shares during the last quarter. Morgan Stanley raised its holdings in shares of CVS Health by 10.9% during the fourth quarter. Morgan Stanley now owns 33,576,388 shares of the pharmacy operator’s stock worth $3,128,984,000 after purchasing an additional 3,311,928 shares during the last quarter. FMR LLC raised its holdings in shares of CVS Health by 29.1% during the third quarter. FMR LLC now owns 27,487,238 shares of the pharmacy operator’s stock worth $1,919,159,000 after purchasing an additional 6,194,441 shares during the last quarter. Finally, Moneta Group Investment Advisors LLC raised its holdings in shares of CVS Health by 103,371.0% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 15,547,559 shares of the pharmacy operator’s stock worth $1,448,877,000 after purchasing an additional 15,532,533 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the sale, the executive vice president now owns 39,765 shares in the company, valued at $3,059,916.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.25% of the stock is currently owned by company insiders.

CVS Health Stock Performance

Shares of CVS Health stock opened at $79.76 on Monday. CVS Health Co. has a one year low of $64.41 and a one year high of $83.25. The company has a market cap of $100.37 billion, a price-to-earnings ratio of 12.35, a PEG ratio of 1.05 and a beta of 0.52. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.86. The business’s 50 day moving average price is $75.91 and its 200 day moving average price is $73.61.

CVS Health (NYSE:CVSGet Free Report) last announced its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm had revenue of $93.81 billion for the quarter, compared to the consensus estimate of $90.58 billion. During the same quarter last year, the business posted $1.99 earnings per share. The firm’s revenue was up 11.9% compared to the same quarter last year. On average, research analysts predict that CVS Health Co. will post 8.33 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be given a dividend of $0.665 per share. The ex-dividend date is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a yield of 3.34%. CVS Health’s payout ratio is 41.18%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on CVS. Piper Sandler raised their target price on shares of CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, March 15th. StockNews.com cut CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. Royal Bank of Canada lowered their price target on CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a research report on Thursday, February 8th. SVB Leerink began coverage on CVS Health in a report on Monday, February 26th. They issued an “outperform” rating and a $88.00 price objective on the stock. Finally, TD Cowen dropped their price objective on CVS Health from $102.00 to $99.00 and set an “outperform” rating on the stock in a report on Monday, December 11th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $89.44.

Check Out Our Latest Stock Report on CVS Health

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Recommended Stories

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.